Delivery Order 36E79726D0010-15B20526F00000089
Award Date 9/15/26
Potential Completion Date 9/15/26
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Summit, NJ 07901, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Seqirus USA Inc., a global biotechnology company, to provide FLUAD TIV, a trivalent or quadrivalent pre-filled single dose syringe (PFS) influenza vaccine, high dose for individuals 65 years and older. The $6,681.33 firm-fixed-price delivery order contract was awarded by the Federal Medical Center Carswell, a civilian agency, and has an ultimate completion date of September 30, 2025. The contract is not set aside and is part of Seqirus's broader portfolio of...
- The Department of Veterans Affairs Veterans Health Administration awarded a $118,161.88 firm fixed price delivery order to Seqirus USA Inc. for the supply of FLUAD QUADRIVALENT 0.5ML SINGLE DOSE SYRINGES designated for persons 65 years and older. The order was placed under Veterans Integrated Service Network 21 and is scheduled for completion by October 15, 2021. Seqirus USA Inc. is a global biotechnology company that specializes in the development and delivery of influenza vaccines, and has...
- This $124,659.50 firm fixed price delivery order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to Seqirus USA Inc., a foreign-owned for-profit manufacturer, to provide FLUAD influenza vaccines for the 2020-2021 season. The contract was not set aside. Seqirus USA Inc. has previously supplied influenza vaccines to various federal agencies including the Department of Defense, Department of Justice Bureau of Prisons, and...
- The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a delivery order to Seqirus USA Inc. for FLUAD TRI influenza vaccines for the 2026-2027 season. This firm fixed-price delivery order, valued at $127,159.40, is scheduled for completion by March 14, 2027, and will be performed at Seqirus's facility in Summit, New Jersey. This delivery order is issued under a larger indefinite delivery contract vehicle, reflecting the VA's ongoing relationship with Seqirus as a...
- The Department of Veterans Affairs Veterans Health Administration awarded a $232,940 delivery order to Seqirus USA Inc. for FLUAD vaccine. The contract has no set-aside designation and requires completion by October 31, 2019. As the sole-source awardee, Seqirus USA Inc. will deliver influenza vaccine to support immunization programs within Veterans Integrated Service Network 12, headquartered in King of Prussia, Pennsylvania. FLUAD is an adjuvanted trivalent influenza vaccine indicated for...
- This is a $9,248.16 firm-fixed-price delivery order contract awarded by the Federal Medical Center Devens, a civilian agency, to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in influenza vaccine manufacturing and supply. The contract is for the delivery of influenza virus vaccines to the FMC Devens staff and inmate population, with 50% of the requirements to be shipped between August 15, 2025, and September 15, 2025, and the remaining 50% delivered on or...
- Seqirus USA Inc. was awarded a $61,300 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The contract calls for Seqirus to provide FLUAD (HIGH DOSE) FLU VACCINE with delivery by October 15, 2019. FLUAD is a high-dose influenza vaccine administered annually to help protect seniors ages 65 years and older from seasonal influenza. No set-aside...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Administration, awarded a $126,580.68 delivery order to Seqirus USA Inc. for flu vaccine supply during the 2025-2026 season. The contract, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), carries a firm fixed price structure with no set-aside designation and an ultimate completion date of August 27, 2025. Performance will be executed from the contractor's facility in Summit, New...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $180,047.92 delivery order contract to Seqirus USA Inc. for the supply of FLUAD QUADRIVALENT 0.5ML single dose syringes designated for persons 65 years and older. The contract has a firm fixed price and period of performance from April 7, 2021 through October 15, 2021. Place of performance will be in Summit, New Jersey. No major subcontractors or set aside designations were...
- The Department of Health and Human Services Indian Health Service awarded a firm fixed price delivery order to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines, to provide 10 boxes of FLUAD 0.5ML PFS - 65 YEARS OLDER and 10 vials of AFLURIA QUAD MDV'S - 5 YRS OLDER for the NSSC customers. The $2,368,593.20 delivery order has an October 15, 2018 completion date and did not use a set-aside. Seqirus USA Inc. has previously held Indefinite Delivery,...